BRIEF — Genmab Q3 Net Sales Of Darzalex At $4.24 Bln

Oct 13 (Reuters) — Genmab A/S: Genmab Announces Net Sales Of Darzalex® (Daratumumab) For Third Quarter Of 2026 Darzalex Q3 2026 Net Sales Total Usd 4.24 Billion Darzalex Q3 2026 Net Sales Usd 2.53 Billion In U.s., Usd 1.71 Billion Rest Of World Source text:... Further company coverage: GMAB.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;)